Operating
Change in Inventories
Pfizer Change in Inventories remained flat by 0.0% to -$140.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 165.7%, from $213.50M to -$140.25M. Over 4 years (FY 2021 to FY 2025), Change in Inventories shows a downward trend with a -16.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase might signal preparation for a major product launch or, conversely, slowing demand and potential future write-downs.
Detailed definition
This metric tracks the change in the value of raw materials, work-in-progress, and finished goods held by the company. A...
Peer comparison
Consumer hardware companies aim for high inventory turnover to minimize the risk of product obsolescence.
Metric ID:
cf_change_in_inventoriesHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.13B | -$592.00M | $1.17B | $854.00M | -$561.00M |
| YoY Change | — | -152.6% | +297.5% | -26.9% | -165.7% |
Range-$592.00M – $1.17B
CAGR-16.0%
Avg YoY Growth-11.9%
Median YoY Growth-89.8%
Current Streak2 years decline
Change in Inventories at Other Companies
Frequently Asked Questions
- What is Pfizer's change in inventories?
- Pfizer (PFE) reported change in inventories of -$140.25M in Q4 2025.
- How has Pfizer's change in inventories changed year-over-year?
- Pfizer's change in inventories decreased by 165.7% year-over-year, from $213.50M to -$140.25M.
- What is the long-term trend for Pfizer's change in inventories?
- Over 4 years (2021 to 2025), Pfizer's change in inventories has grown at a -16.0% compound annual growth rate (CAGR), from $1.13B to -$561.00M.
- What does change in inventories mean?
- The change in the value of products and materials the company has in stock.